UY28622A1 - Agentes antibacterianos de quinolona - Google Patents

Agentes antibacterianos de quinolona

Info

Publication number
UY28622A1
UY28622A1 UY28622A UY28622A UY28622A1 UY 28622 A1 UY28622 A1 UY 28622A1 UY 28622 A UY28622 A UY 28622A UY 28622 A UY28622 A UY 28622A UY 28622 A1 UY28622 A1 UY 28622A1
Authority
UY
Uruguay
Prior art keywords
antibacterial agents
iii
formula
quinolona
compounds
Prior art date
Application number
UY28622A
Other languages
English (en)
Inventor
Denton Wade Hoyer
Chris Limberakis
Clarke Bentley Taylor
Edmund Lee Ellsworth
Sean Timothy Murphy
Mark Ryan Rauckhorst
Jeremy Tyson Starr
Kim Marie Hutchings
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of UY28622A1 publication Critical patent/UY28622A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen compuestos de fórmula I, II, III, v, V y VI y procedimientos para su preparación. Tambie´n se describen procedimientos para fabricar compuestos biológicamente activos de fórmula I, II, III, IV, V y VI a´sí como composiciones farmacéuticamente aceptables que comprenden compuestos de fórmula I, II, III, IV, V y VI. Los compuestos de fórmula I, II, III, IV, V y VI, como se describen en este documento, pueden usarse en diversas aplicaciones incluyendo su uso como agentes antibacterianos.
UY28622A 2003-11-18 2004-11-17 Agentes antibacterianos de quinolona UY28622A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52307103P 2003-11-18 2003-11-18
US60549604P 2004-08-31 2004-08-31

Publications (1)

Publication Number Publication Date
UY28622A1 true UY28622A1 (es) 2005-06-30

Family

ID=34623167

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28622A UY28622A1 (es) 2003-11-18 2004-11-17 Agentes antibacterianos de quinolona

Country Status (6)

Country Link
AR (1) AR046638A1 (es)
NL (1) NL1027545C2 (es)
PE (1) PE20050582A1 (es)
TW (1) TW200524930A (es)
UY (1) UY28622A1 (es)
WO (1) WO2005049602A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004272414B2 (en) 2003-09-10 2009-05-28 Kyorin Pharmaceutical Co., Ltd. 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) quinolonecarboxylic acid derivative
WO2007019416A1 (en) 2005-08-04 2007-02-15 Sirtris Pharmaceuticals, Inc. Benzimidazole derivatives as sirtuin modulators
DE102006005861A1 (de) * 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituierte Chinolone III
PT2097400E (pt) * 2007-01-05 2013-10-10 Daiichi Sankyo Co Ltd Derivado de aminopirrolidina substituido fundido
CN101622240B (zh) * 2007-01-05 2014-07-23 第一三共株式会社 稠合取代氨基吡咯烷衍生物
WO2008143343A1 (ja) 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
DE102007036068A1 (de) * 2007-08-01 2009-02-05 Wacker Chemie Ag Verfahren zur Herstellung von Alkyl-methoxymethyl-trimethylsilanylmethylaminen
WO2009145286A1 (ja) 2008-05-30 2009-12-03 武田薬品工業株式会社 複素環化合物
KR101677778B1 (ko) 2009-02-06 2016-11-18 니뽄 신야쿠 가부시키가이샤 아미노피라진 유도체 및 의약
AR091858A1 (es) 2012-07-25 2015-03-04 Sova Pharmaceuticals Inc INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
SG11201710164QA (en) 2015-06-09 2018-01-30 Bayer Pharma AG Positive allosteric modulators of muscarinic m2 receptor
CA3030204A1 (en) * 2016-07-11 2018-01-18 Bayer Pharma Aktiengesellschaft 7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof
EP3296298A1 (de) 2016-09-14 2018-03-21 Bayer Pharma Aktiengesellschaft 7-substituierte 1-aryl-naphthyridin-3-carbonsäureamide und ihre verwendung
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
US20190218188A1 (en) 2016-09-29 2019-07-18 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazole derivatives

Also Published As

Publication number Publication date
NL1027545A1 (nl) 2005-05-23
WO2005049602A1 (en) 2005-06-02
TW200524930A (en) 2005-08-01
PE20050582A1 (es) 2005-08-25
AR046638A1 (es) 2005-12-14
NL1027545C2 (nl) 2006-01-17

Similar Documents

Publication Publication Date Title
BRPI0507653A (pt) derivados de imidazopiridina e imidazopiridina formulação farmacêutica compreendendo os mesmos e uso
UY27760A1 (es) Nuevos derivados de pirrolidinio.
UY28622A1 (es) Agentes antibacterianos de quinolona
UY28514A1 (es) Nuevos compuestos
CR8559A (es) Pirazolopirimidinas
UY28513A1 (es) Nuevos compuestos
UY27571A1 (es) 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
UY27381A1 (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
BRPI0212137A2 (pt) diidropteridinonas, processos para prepará-las e seu uso como composições farmacêuticas
UY30327A1 (es) Nuevos compuestos ii
UY28510A1 (es) Compuestos quimicos
UY29420A1 (es) Derivados de 2-piridona,composiciones que los contienen, procesos de preparación y aplicación
CL2003002770A1 (es) Compuestos derivados de pirrol e imiddazol; composiciones farmaceuticas que los contienen; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de enfermedades que estan asociadas con la modulacion de los receptores a canabinoides
UY31071A1 (es) Derivados heterociclicos sustituidos y su uso farmaceutico y composiciones
BR0107770A (pt) Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
UY28694A1 (es) Nuevos compuestos
UY29234A1 (es) Derivados de adamantano, composiciones farmacéuticas que los contienen, procedimientos de preparación de ambos y aplicaciones.
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
CL2004001678A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica; y uso de los compuestos como agentes bacterianos.
ECSP066275A (es) Piridinilanilidas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150525